PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)
CME Available: auau.auanet.org/node/39603
Release Date: December, 2023
Expiration Date: December, 2024
LEARNING OBJECTIVES:
At the conclusion of this activity, the learner will be able to:
1. Review recommended criteria for genetic testing of prostate cancer patients, currently available gene panels, and options for testing these men.
2. Explain the importance of testing for germline and somatic mutations and their implications for utilizing PARPi.
3. Describe work flows for genetic testing and utilization of genetic counselors.
4. Describe the genetic counseling process and the importance of pre-test counseling to discuss the benefits, limitations, and potential implications of germline testing for patients and their families.
ACKNOWLEDGEMENT
This educational activity is supported by an independent educational grant from Pfizer, Inc.